April 30, 2021: Last week, the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) lifted the temporary recommended pause of use on the Johnson & Johnson (J&J) COVID-19 vaccine. The Pennsylvania Department of Health has also advised vaccine providers that they can resume use of the J&J vaccine in Pennsylvania.
We recognize that there may be some concern and hesitancy specifically towards the J&J vaccine now that it is available again, and we’d like to share a bit of information to help you weigh your options regarding the vaccines available.
By recommending that the country resume using the J&J vaccine, the CDC and FDA are affirming the J&J vaccine’s overall safety. The agencies’ joint statement on the return is available here, but we would like to highlight a few points. Read more.